Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis

Clinical trial NCT01622348 · COMPLETED

Trial details

NCT number: NCT01622348
Sponsor: Idera Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Actively Extending Plaque Psoriasis Moderate to Severe Plaque Psoriasis

Start date: 2012-05-01
Primary completion: 2012-11-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.